CGON position history
The shares of CG Oncology (CGON) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q1: 163,988 shares, $4M, 0.89% of portfolio, New
- 2025 Q2: 532,000 shares, $14M, 2.8% of portfolio, Add +224.4%
- 2025 Q3: 410,000 shares, $17M, 2.3% of portfolio, Reduce −22.9%
- 2025 Q4: 820,000 shares, $34M, 4.5% of portfolio, Add +100.0%
- 2026 Q1: 94,800 shares, $6.4M, 0.85% of portfolio, Reduce −88.4%
- 2026 Q2: 17,789 shares, $1.3M, 0.11% of portfolio, Reduce −81.2%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|